McGuirk, Joseph P. http://orcid.org/0000-0002-0539-4796
Metheny, Leland III http://orcid.org/0000-0002-1980-9999
Pineiro, Luis
Litzow, Mark http://orcid.org/0000-0002-9816-6302
Rowley, Scott D. http://orcid.org/0000-0002-3299-835X
Avni, Batia
Tamari, Roni http://orcid.org/0000-0002-2386-0850
Lazarus, Hillard M. http://orcid.org/0000-0002-1159-5607
Rowe, Jacob M.
Sheleg, Michal
Rothenstein, Daniel
Halevy, Nitsan
Zuckerman, Tsila http://orcid.org/0000-0002-6204-977X
Funding for this research was provided by:
Pluri Biotech, Ltd.
Pluri-Biotch Ltd.
Pluri-Biotech, Ltd.
Pluri Biotech Ltd.
Article History
Received: 17 February 2023
Revised: 12 July 2023
Accepted: 21 July 2023
First Online: 8 August 2023
Competing interests
: JPM has declared the following competing interests: Kite, Novartis, Bristol Myers Squibb, Allovir, Nektar, Sana, CRISPR (Ad Boards and consulting). LM has declared the following competing interests: Incyte (promotional speaker). LP has no competing interests. ML has declared the following competing interests: clinical trial finding (Abbvie, Amgen, Astellas, Novartis, Syndax, Actinium, Pluri-Biotech); advisory board (Jazz Pharmaceuticals); data monitoring board (BioSight). SDR has declared the following competing interests: SIRPant Immunotherapeutics (community advisory board), Realta Life Sciences (consultant). BA has no competing financial interests. RT has no competing financial interests. HML has declared the following competing interests: Actinium pharmaceuticals, Inc (consultant); Partner Therapeutics (consultant and stock options); Jazz Pharmaceuticals (speaker bureau and consultant); Pluri-Biotech, Inc.(consultant); Bristol-Myers Squibb (data safety monitoring board); Seattle Genetics (consultant and promotional speaker); AstraZeneca (promotional speaker); BioSight (data safety monitoring board); CSL Behring (consultant). JMR has declared the following competing interests: BioSight (consultant); Pluri-Biotech, Inc. (consultant). TZ has received honoraria from AbbVie, Orgenesis Inc, BioSight Ltd, Cellect Biotechnology, Janssen, Novartis and Gilead Sciences for participating in an advisory board or speaker’s bureau. MS, DR and NH are current employees of Pluri-Biotech.